The prognosis of patients with heart failure can be predicted by quantitative assessment of several variables including left ventricular ejection fraction, peak O2 consumption during exercise, plasma norepinephrine concentration and ventricular arrhythmias on Holter monitoring. Vasodilator therapy may favourably influence the survival predicted from these baseline variables. Therefore, assessment of the risk of mortality in an individual patient or in a study group can be best accomplished by measuring these baseline variables.
|Number of pages
|Round Table Series - Royal Society of Medicine
|Published - Jan 1 1987